Ion Beam Applications, SA Share Price

Equities

IBAB

BE0003766806

Advanced Medical Equipment & Technology

Market Closed - Euronext Bruxelles 09:05:18 26/04/2024 pm IST 5-day change 1st Jan Change
12.86 EUR -0.77% Intraday chart for Ion Beam Applications, SA -3.02% +11.44%

Financials

Sales 2023 429M 458M 38.23B Sales 2024 * 489M 523M 43.62B Capitalization 375M 401M 33.46B
Net income 2023 -9M -9.62M -803M Net income 2024 * 4M 4.28M 357M EV / Sales 2023 0.63 x
Net cash position 2023 68.46M 73.2M 6.11B Net cash position 2024 * 62.79M 67.14M 5.6B EV / Sales 2024 * 0.64 x
P/E ratio 2023 *
-25.7 x
P/E ratio 2024 *
91.9 x
Employees 2,000
Yield 2023 *
1.63%
Yield 2024 *
2.1%
Free-Float 65.88%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.77%
1 week-3.02%
Current month-1.83%
1 month+7.17%
3 months+22.71%
6 months+44.98%
Current year+11.44%
More quotes
1 week
12.80
Extreme 12.8
13.46
1 month
12.78
Extreme 12.78
14.00
Current year
9.31
Extreme 9.31
14.00
1 year
8.26
Extreme 8.26
17.20
3 years
8.26
Extreme 8.26
20.45
5 years
6.01
Extreme 6.01
20.45
10 years
6.01
Extreme 6.01
56.94
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01/96/01
Founder 76 28/86/28
Director of Finance/CFO 46 01/04/01
Members of the board TitleAgeSince
Chairman 63 01/87/01
Director/Board Member 77 01/17/01
Founder 76 28/86/28
More insiders
Date Price Change Volume
26/24/26 12.86 -0.77% 19,328
25/24/25 12.96 -2.56% 17,204
24/24/24 13.3 0.00% 7,679
23/24/23 13.3 +0.91% 17,590
22/24/22 13.18 -0.60% 14,637

Real-time Euronext Bruxelles, April 26, 2024 at 09:05 pm IST

More quotes
Ion Beam Applications, SA (IBA) specializes in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. Net sales break down by family of products as follows: - diagnosis and therapeutic treatment equipment and systems (84.8%): proton therapy equipment (62.5% of net sales; No. 1 worldwide), and particle accelerators (36.5%) used in the production of radioisotopes (cyclotrons) and in the development of sterilization and ionization solutions (Rhodotron® and Dynamitron®); - equipment and solutions of dosimetry (15.2%; No. 1 worldwide): measurement and analysis tools of the radiation doses in medical imaging and radiation therapy. Net sales are distributed geographically as follows: the United States (31.7%) and other (68.3%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.86 EUR
Average target price
16.17 EUR
Spread / Average Target
+25.71%
Consensus

Quarterly revenue - Rate of surprise